Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauro Riccardi

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
ESC Heart Failure|December 22, 2022
Heart failure: an update from the last years and a look at the near futureMauro Riccardi, Antonio Maria Sammartino, Massimo Piepoli, et al.
European Journal of Heart Failure|February 23, 2024
Medical therapy of cardiogenic shock: Contemporary use of inotropes and vasopressorsMauro Riccardi, Matteo Pagnesi, Ovidiu Chioncel, et al.
Journal of the American College of Cardiology|September 10, 2025
Moderate Secondary Mitral Regurgitation: Evolving Evidence and Management StrategiesMauro Riccardi, Matteo Pagnesi, Carlo M Lombardi, et al.
Journal of Clinical Medicine|August 14, 2025
Current Treatment of Heart Failure with Preserved Ejection FractionMauro Riccardi, Emilia D'Elia, Carlo M Lombardi, et al.
ESC Heart Failure|December 25, 2024
Prognostic role of TAPSE to PASP ratio in outpatients with left ventricular systolic dysfunctionMauro Riccardi, Matteo Pagnesi, Rossana Corso, et al.
Journal of the American College of Cardiology|June 18, 2025
Heart Failure With Improved Ejection Fraction: Definitions, Epidemiology, and ManagementMauro Riccardi, Maria A Pabon, Ankeet S Bhatt, et al.
Heart Failure Reviews|May 17, 2023
Cardiac contractility modulation: an effective treatment strategy for heart failure beyond reduced left ventricular ejection fraction?Mauro Riccardi, Antonio M Sammartino, Marianna Adamo, et al.
Frontiers in Cardiovascular Medicine|June 8, 2023
Treating amyloid transthyretin cardiomyopathy: lessons learned from clinical trialsDaniela Tomasoni, Giovanni Battista Bonfioli, Alberto Aimo, et al.
ESC Heart Failure|February 19, 2026
Clinical and echocardiographic changes after intermittent levosimendan infusion in patients with advanced heart failureMauro Riccardi, Emilia D'Elia, Fabio Fazzari, et al.
ESC Heart Failure|September 10, 2025
Epidemiology, pathophysiology, diagnosis and management of atrial functional mitral regurgitation: An expert opinion paperMatteo Pagnesi, Mauro Riccardi, Francesco Maisano, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
ESC Heart Failure|December 22, 2022
Heart failure: an update from the last years and a look at the near futureMauro Riccardi, Antonio Maria Sammartino, Massimo Piepoli, et al.
European Journal of Heart Failure|February 23, 2024
Medical therapy of cardiogenic shock: Contemporary use of inotropes and vasopressorsMauro Riccardi, Matteo Pagnesi, Ovidiu Chioncel, et al.
Journal of the American College of Cardiology|September 10, 2025
Moderate Secondary Mitral Regurgitation: Evolving Evidence and Management StrategiesMauro Riccardi, Matteo Pagnesi, Carlo M Lombardi, et al.
Journal of Clinical Medicine|August 14, 2025
Current Treatment of Heart Failure with Preserved Ejection FractionMauro Riccardi, Emilia D'Elia, Carlo M Lombardi, et al.
ESC Heart Failure|December 25, 2024
Prognostic role of TAPSE to PASP ratio in outpatients with left ventricular systolic dysfunctionMauro Riccardi, Matteo Pagnesi, Rossana Corso, et al.
Journal of the American College of Cardiology|June 18, 2025
Heart Failure With Improved Ejection Fraction: Definitions, Epidemiology, and ManagementMauro Riccardi, Maria A Pabon, Ankeet S Bhatt, et al.
Heart Failure Reviews|May 17, 2023
Cardiac contractility modulation: an effective treatment strategy for heart failure beyond reduced left ventricular ejection fraction?Mauro Riccardi, Antonio M Sammartino, Marianna Adamo, et al.
Frontiers in Cardiovascular Medicine|June 8, 2023
Treating amyloid transthyretin cardiomyopathy: lessons learned from clinical trialsDaniela Tomasoni, Giovanni Battista Bonfioli, Alberto Aimo, et al.
ESC Heart Failure|February 19, 2026
Clinical and echocardiographic changes after intermittent levosimendan infusion in patients with advanced heart failureMauro Riccardi, Emilia D'Elia, Fabio Fazzari, et al.
ESC Heart Failure|September 10, 2025
Epidemiology, pathophysiology, diagnosis and management of atrial functional mitral regurgitation: An expert opinion paperMatteo Pagnesi, Mauro Riccardi, Francesco Maisano, et al.
Pageof 4